We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Prolonged RBC Storage before Transfusion Increases Extravascular Hemolysis

By LabMedica International staff writers
Posted on 02 Feb 2017
Print article
Red blood cell transfusion, the most common procedure performed on hospitalized patients, is an indispensable component of modern medicine and establishing an adequate blood supply depends on the ability to store donated red cells safely.

Some countries have limited the maximum allowable storage duration for red cells to five weeks before transfusion, while in the USA, red blood cells can be stored for up to six weeks, but randomized trials have not assessed the effects of this final week of storage on clinical outcomes.

Scientists at the Columbia University Medical Center and their colleagues randomly assigned a group of 60 healthy volunteers to receive a unit of red blood cells that had been stored for 1, 2, 3, 4, 5, or 6 weeks. The volunteers were then monitored for 20 hours after transfusion. Chromium-51 (51Cr) post transfusion red cell recovery studies were performed and laboratory parameters measured before and at defined times after transfusion.

Routine laboratory parameters were measured and transferrin saturation and total iron binding capacity were calculated from the measured serum iron and unbound iron-binding capacity. Nontransferrin-bound iron was measured using an ultrafiltration assay and this method correlated well with other techniques. Plasma-free hemoglobin was measured by a modified cyanomethemoglobin method. Commercial enzyme-linked immunosorbent assay (ELISA) kits were used to measure Hepcidin and interleukin -6.

The authors found that extravascular hemolysis after transfusion progressively increased with increasing storage time. Longer storage duration was associated with decreasing post-transfusion red cell recovery, decreasing elevations in hematocrit, and increasing serum ferritin. After six weeks of refrigerated storage, transfusion was followed by increases in area under the curve (AUC) for serum iron, transferrin saturation, and nontransferrin-bound iron as compared with transfusion after one to five weeks of storage. Within hours after transfusion, seven of the nine volunteers who received the 6-week-old blood could not appropriately metabolize the damaged cells, thereby releasing large amounts of iron into their bloodstream.

Eldad A. Hod, MD. Assistant Professor of Pathology and senior author of the study said, “Based on the amount of iron circulating in the blood of the volunteers who received six-week-old blood, we'd predict that certain existing infections could be exacerbated. It's estimated that up to 10% to 20% of blood units used for transfusions have been stored for more than five weeks, so the number of patients who are likely to receive a unit of very old blood is substantial.” The study was published in the January 2017 issue of the Journal of Clinical Investigation.

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The test monitors blood levels of DNA fragments released by dying tumor cells (Photo courtesy of 123RF)

Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer

Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.